Related Experiment Video
Updated: Aug 9, 2026

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
Published on: February 23, 2015
Premenstrual depression, cortisol and oestradiol treatment
Hormone replacement therapy, specifically an oestradiol/testosterone implant, effectively treated a woman with recurrent depression. This treatment normalized plasma cortisol levels and resolved symptoms for over 8 years.
Area of Science:
- Endocrinology
- Neuroscience
- Psychiatry
Background:
- Recurrent depression can be treatment-resistant.
- Hormonal imbalances, such as raised plasma cortisol, may contribute to depressive illness.
Observation:
- A patient with a 5-year history of recurrent depression showed poor response to standard antidepressants.
- Her condition was exacerbated by progesterone and adrenocorticotropic hormone (ACTH), with elevated plasma cortisol.
Findings:
- Sustained remission from depressive symptoms was achieved for over 8 years using an oestradiol/testosterone implant administered every 4 months.
- This hormonal intervention normalized elevated plasma cortisol levels.
Implications:
- This case highlights a potential hormonal aetiology for some forms of depression.
- Findings suggest hormone replacement therapy as a novel therapeutic avenue for specific depressive disorders.
- The study offers insights into the relationship between sex hormones, cortisol, and mood regulation, relevant to premenstrual syndromes.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Related Concept Videos
Oogenesis
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Ovarian Cycle
Disorders of the Female Reproductive System
Menopause